Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Lyophilised vs Reconstituted TB-500 Storage Requirements

Lyophilised (freeze-dried) TB-500 arrives as a powder in sealed vials under vacuum. In this form, the peptide is stable at −20°C for 12–24 months depending on manufacturer synthesis date. The lyophilisation process removes water molecules that would otherwise

This comparison does not assign a generated winner or score.

  • Lyophilised (freeze-dried) TB-500 arrives as a powder in sealed vials under vacuum. In this form, the peptide is stable at −20°C for 12–24 months depending on manufacturer synthesis date. The lyophilisation process removes water molecules that would otherwise catalyse peptide bond hydrolysis. But it doesn't eliminate the need for cold storage. Even in powder form, TB-500 stored at room temperature for more than 72 hours begins measurable degradation, particularly if humidity exceeds 40%. Research facilities in coastal or tropical regions must account for ambient moisture when calculating storage timelines.
  • Once reconstituted with bacteriostatic water (0.9% benzyl alcohol), the degradation timeline compresses dramatically. The peptide is now in aqueous solution where hydrolytic enzymes. Even trace amounts introduced during mixing. Can cleave peptide bonds. At 2–8°C, reconstituted TB-500 maintains at least 95% potency for 28 days. At 15°C (common in poorly calibrated mini-fridges), that window drops to 7–10 days. At 25°C (room temperature), potency drops below research-grade thresholds within 48 hours. The mechanism isn't oxidation. TB-500's cysteine residues are relatively stable in neutral pH bacteriostatic water. The issue is conformational drift: the peptide's tertiary structure, which determines receptor binding affinity, unfolds as thermal energy breaks hydrogen bonds holding the folded configuration in place.
  • Freeze-thaw cycles compound the problem. Each freeze-thaw event causes ice crystal formation that physically disrupts the peptide backbone. One cycle reduces potency by approximately 8–12%. Two cycles push degradation past 20%. Three cycles render the solution unreliable for any receptor-binding assay or in vivo study. The issue isn't the freezing itself. It's the rate of freezing and the mechanical stress during thaw. Standard −20°C freezers cycle on and off to maintain temperature, creating micro-thaws research teams often don't detect. Our experience working with peptide stability protocols shows that facilities using ultra-low −80°C freezers for long-term storage avoid this issue entirely, but few labs maintain that infrastructure for every peptide in rotation.
More references

Related material